Product Information

BUPRENORPHINE 5 MCG/HR PATCH is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $24.0850 per EA under NDC 42858075040. Its NADAC has been published 474 times since Oct 18, 2017.

FDA first approved this application on Jun 30, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUPRENORPHINE 5 MCG/HR PATCH

Buprenorphine
$24.0850per EA
DEA Schedule CIII

Strength

5 ug/h

NDC

42858075040

Classification

Generic

Dosage Form

PATCH

Route

TRANSDERMAL

Effective Date

10/21/2026

Active Ingredients

BUPRENORPHINE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021306

FDA Approved

6/30/2010

TE Code

AB

On Market Since

7/3/2017

Pharmacological Classes

Partial Opioid Agonist
Partial Opioid Agonists

Price Statistics

The NADAC for BUPRENORPHINE 5 MCG/HR PATCH has been published 474 times since Oct 18, 2017, and over the history we have for it it has declined 46.3%. The table below summarizes its recorded NADAC range and movement.

Current price$24.0850 per EA
All-time high$52.5979 (Mar 13, 2019)
All-time low$19.0169 (May 22, 2024)
52-week high$24.0850
52-week low$20.8287
Median price$37.2490
Average price$36.5554
Largest weekly change-32.9% (Jun 21, 2023)
Weeks tracked474
Tracking sinceOct 18, 2017

Price History

1W

0.0%

1M

+2.7%

3M

+5.1%

6M

+5.6%

1Y

+8.7%

3Y

-25.8%

5Y

-47.9%

All

-46.3%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUPRENORPHINE 5 MCG/HR PATCH?

The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE 5 MCG/HR PATCH, manufactured by Rhodes Pharmaceuticals L.P., is $24.0850 per EA (NDC 42858075040), effective Nov 11, 2026.

How has the price of BUPRENORPHINE 5 MCG/HR PATCH changed over time?

Over the history we have for it, the NADAC for BUPRENORPHINE 5 MCG/HR PATCH has declined 46.3%. It has been tracked across 474 weekly CMS publications since Oct 18, 2017.

What are the highest and lowest recorded NADAC prices for BUPRENORPHINE 5 MCG/HR PATCH?

Since Oct 18, 2017, the NADAC for BUPRENORPHINE 5 MCG/HR PATCH has ranged from a low of $19.0169 (May 22, 2024) to a high of $52.5979 (Mar 13, 2019), with a median of $37.2490 per EA.

Are there cheaper alternatives to BUPRENORPHINE 5 MCG/HR PATCH?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPRENORPHINE 5 MCG/HR PATCH in a comparable dosage form, but none are currently priced below it.

Who manufactures BUPRENORPHINE 5 MCG/HR PATCH?

BUPRENORPHINE 5 MCG/HR PATCH (NDC 42858075040) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.